Washington, DC - As we continue to address the troubling epidemic of youth e-cigarette use, we’ve committed to employing a number of tools as part of our Youth Tobacco Prevention Plan to ensure no tobacco products are being marketed to, sold to, or used by kids. We’ve taken a series of escalating enforcement actions. We’ve launched public education campaigns to warn youth about the dangers of e-cigarette and other tobacco product use. And most recently, we advanced new policies aimed at preventing youth access to, and appeal of, flavored tobacco products, including e-cigarettes and cigars.

Washington, DC - The U.S. Food and Drug Administration approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

Washington, DC - The U.S. Department of Agriculture (USDA) in coordination with the U.S. Department of Health and Human Services (HHS), invites the public to register to attend the first meeting of the 2020 Dietary Guidelines Advisory Committee. The meeting will be held at USDA headquarters in the Jefferson Auditorium on March 28th and 29th. Registration for in-person attendance begins today and closes at 5:00 p.m. March 26, 2019.

Washington, DC - McAllen Cold Storage, Ltd., a McAllen, Texas establishment, is recalling approximately 51,942 pounds of frozen Siluriformes fish products, specifically Basa fillets, that were not presented for import re-inspection into the United States, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced Tuesday.

Washington, DC - Presidential Message on National Colorectal Cancer Awareness Month:

Washington, DC - The U.S. Food and Drug Administration has issued a warning letter to Total Thermal Imaging Inc., of La Mesa, California, and its president and co-owner, Linda Hayes, for illegally marketing and distributing an unapproved thermography device as a sole screening device for breast cancer and other diseases. The FDA also issued a safety communication to warn patients that thermography is not cleared by the FDA as an alternative to mammography and should not replace mammography for breast cancer screening or diagnosis.